Use. of vildagliptin for the treatment of diabetes

Details for Australian Patent Application No. 2007238522 (hide)

Owner Novartis AG

Inventors Foley, James E.

Agent Davies Collison Cave

Pub. Number AU-A-2007238522

PCT Pub. Number WO2007/120936

Priority 60/757,051 06.01.06 US; 60/772,655 13.02.06 US

Filing date 4 January 2007

Wipo publication date 25 October 2007

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

17 July 2008 PCT application entered the National Phase

  PCT publication WO2007/120936 Priority application(s): WO2007/120936

20 August 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Use of vildagliptin for the treatment of diabetes

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238528-Hydrogen-generating fuel cell cartridges

2007238520-Method and system for nitrifying and denitrifying wastewater